These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 34678705)

  • 1. Application of liquid chromatography coupled to data-independent acquisition mass spectrometry for the metabolic profiling of N-ethyl heptedrone.
    Mazzarino M; Camuto C; Comunità F; de la Torre X; Stacchini C; Botrè F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Nov; 1185():122989. PubMed ID: 34678705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the biotransformation pathways of clomiphene, tamoxifen and toremifene as assessed by LC-MS/(MS) following in vitro and excretion studies.
    Mazzarino M; Biava M; de la Torre X; Fiacco I; Botrè F
    Anal Bioanal Chem; 2013 Jun; 405(16):5467-87. PubMed ID: 23604525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the phase I and phase II metabolic profile of tolvaptan by in vitro studies and liquid chromatography-mass spectrometry profiling: Relevance to doping control analysis.
    Mazzarino M; Buccilli V; de la Torre X; Fiacco I; Palermo A; Ughi D; Botrè F
    J Pharm Biomed Anal; 2017 Oct; 145():555-568. PubMed ID: 28759864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biotransformation and detectability of the new psychoactive substances N,N-diallyltryptamine (DALT) derivatives 5-fluoro-DALT, 7-methyl-DALT, and 5,6-methylenedioxy-DALT in urine using GC-MS, LC-MS
    Michely JA; Brandt SD; Meyer MR; Maurer HH
    Anal Bioanal Chem; 2017 Feb; 409(6):1681-1695. PubMed ID: 27933361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the metabolism of the fentanyl-derived designer drug butyrfentanyl in human in vitro liver preparations and authentic human samples using liquid chromatography-high resolution mass spectrometry (LC-HRMS).
    Steuer AE; Williner E; Staeheli SN; Kraemer T
    Drug Test Anal; 2017 Jul; 9(7):1085-1092. PubMed ID: 27736030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of the tryptamine-derived new psychoactive substances 5-MeO-2-Me-DALT, 5-MeO-2-Me-ALCHT, and 5-MeO-2-Me-DIPT and their detectability in urine studied by GC-MS, LC-MS
    Caspar AT; Gaab JB; Michely JA; Brandt SD; Meyer MR; Maurer HH
    Drug Test Anal; 2018 Jan; 10(1):184-195. PubMed ID: 28342193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic profiling of five flavonoids from Dragon's Blood in human liver microsomes using high-performance liquid chromatography coupled with high resolution mass spectrometry.
    Li Y; Zhang Y; Wang R; Wei L; Deng Y; Ren W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 May; 1052():91-102. PubMed ID: 28376352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low resolution and high resolution MS for studies on the metabolism and toxicological detection of the new psychoactive substance methoxypiperamide (MeOP).
    Meyer MR; Holderbaum A; Kavanagh P; Maurer HH
    J Mass Spectrom; 2015 Oct; 50(10):1163-74. PubMed ID: 26456786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diphenidine, a new psychoactive substance: metabolic fate elucidated with rat urine and human liver preparations and detectability in urine using GC-MS, LC-MS
    Wink CS; Michely JA; Jacobsen-Bauer A; Zapp J; Maurer HH
    Drug Test Anal; 2016 Oct; 8(10):1005-1014. PubMed ID: 26811026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of the new psychoactive substances N,N-diallyltryptamine (DALT) and 5-methoxy-DALT and their detectability in urine by GC-MS, LC-MSn, and LC-HR-MS-MS.
    Michely JA; Helfer AG; Brandt SD; Meyer MR; Maurer HH
    Anal Bioanal Chem; 2015 Oct; 407(25):7831-42. PubMed ID: 26297461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LC-high resolution-MS/MS for identification of 69 metabolites of the new psychoactive substance 1-(4-ethylphenyl-)-N-[(2-methoxyphenyl)methyl] propane-2-amine (4-EA-NBOMe) in rat urine and human liver S9 incubates and comparison of its screening power with further MS techniques.
    Caspar AT; Westphal F; Meyer MR; Maurer HH
    Anal Bioanal Chem; 2018 Jan; 410(3):897-912. PubMed ID: 28762065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of the active metabolite of quetiapine, N-desalkylquetiapine in vitro.
    Bakken GV; Molden E; Knutsen K; Lunder N; Hermann M
    Drug Metab Dispos; 2012 Sep; 40(9):1778-84. PubMed ID: 22688609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic profile determination of 25N-NBOMe in human liver microsomes by liquid chromatography-quadrupole time-of-flight mass spectrometry.
    Seo H; Kim IS; Kim YH; Yoo HH; Hong J
    Int J Legal Med; 2019 May; 133(3):833-841. PubMed ID: 30090972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro Phase I and Phase II metabolism of the new designer benzodiazepine cloniprazepam using liquid chromatography coupled to quadrupole time-of-flight mass spectrometry.
    Mortelé O; Vervliet P; Gys C; Degreef M; Cuykx M; Maudens K; Covaci A; van Nuijs ALN; Lai FY
    J Pharm Biomed Anal; 2018 May; 153():158-167. PubMed ID: 29494888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro studies on flubromazolam metabolism and detection of its metabolites in authentic forensic samples.
    Noble C; Mardal M; Bjerre Holm N; Stybe Johansen S; Linnet K
    Drug Test Anal; 2017 Aug; 9(8):1182-1191. PubMed ID: 27935260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro metabolic profile of mexedrone, a mephedrone analog, studied by high- and low-resolution mass spectrometry.
    Camuto C; Guglielmelli A; De-Giorgio F; de la Torre X; Mazzarino M; Marti M; Botrè F
    Drug Test Anal; 2022 Feb; 14(2):269-276. PubMed ID: 34652887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro phase I metabolism of three phenethylamines 25D-NBOMe, 25E-NBOMe and 25N-NBOMe using microsomal and microbial models.
    Grafinger KE; Stahl K; Wilke A; König S; Weinmann W
    Drug Test Anal; 2018 Oct; 10(10):1607-1626. PubMed ID: 29971945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Qualitative studies on the metabolism and the toxicological detection of the fentanyl-derived designer drugs 3-methylfentanyl and isofentanyl in rats using liquid chromatography-linear ion trap-mass spectrometry (LC-MS(n)).
    Meyer MR; Dinger J; Schwaninger AE; Wissenbach DK; Zapp J; Fritschi G; Maurer HH
    Anal Bioanal Chem; 2012 Jan; 402(3):1249-55. PubMed ID: 22065349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic fate, mass spectral fragmentation, detectability, and differentiation in urine of the benzofuran designer drugs 6-APB and 6-MAPB in comparison to their 5-isomers using GC-MS and LC-(HR)-MS(n) techniques.
    Welter J; Brandt SD; Kavanagh P; Meyer MR; Maurer HH
    Anal Bioanal Chem; 2015 May; 407(12):3457-70. PubMed ID: 25711990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic profiling of synthetic cannabinoid 5F-ADB by human liver microsome incubations and urine samples using high-resolution mass spectrometry.
    Yeter O; Ozturk YE
    Drug Test Anal; 2019 Jun; 11(6):847-858. PubMed ID: 30610752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.